Skip to main content
Contact Us
Subscribe
E-Edition
64°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Illumina, Inc. - Common Stock
(NQ:
ILMN
)
71.20
-2.33 (-3.17%)
Official Closing Price
Updated: 4:15 PM EDT, Apr 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Illumina, Inc. - Common Stock
< Previous
1
2
...
25
26
27
28
29
30
31
32
Next >
Kansas City Lights the Night with a New Research Institute
April 30, 2021
SOURCE: Illumina
Via
3BL Media
Stock Market Rally Navigates Earnings From Apple, Tesla, Google, Facebook, Microsoft, Amazon
April 30, 2021
The stock market rally navigated earnings from Apple, Tesla and the other "big six" market cap companies. Many breakouts, but not all succeeded.
Via
Investor's Business Daily
Illumina To Webcast Upcoming Investor Conference
April 29, 2021
From
Illumina, Inc.
Via
Business Wire
Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics Initiative
April 28, 2021
SOURCE: Illumina
Via
3BL Media
Earnings Scheduled For April 27, 2021
April 27, 2021
Companies Reporting Before The Bell • Camden National (NASDAQ:CAC) is projected to report quarterly earnings at $1.01 per share on revenue of $45.73 million. •...
Via
Benzinga
Illumina Celebrates Earth Day
April 22, 2021
SOURCE: Illumina
Via
3BL Media
Illumina Files Action for Annulment of European Commission’s Decision Asserting Jurisdiction to Review GRAIL Acquisition
April 29, 2021
From
Illumina, Inc.
Via
Business Wire
Time100 Most Influential Companies: What 61 Publicly Traded Companies Are On The Inaugural List?
April 28, 2021
Time Magazine is well-known for its annual Time100 Most Influential People issue. The media brand unveiled a new annual list called the TIME100 Most Influential Companies. ...
Via
Benzinga
Precision Medicine Market to Witness Massive Growth from 2021 to 2026 : Pfizer, AstraZeneca, GE Healthcare
April 21, 2021
Latest added Global Precision Medicine Market research study by HTF MI offers detailed product outlook and elaborates market review till 2026. The market Study is segmented by key a region that is...
Via
SBWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics Initiative
April 28, 2021
From
Illumina, Inc.
Via
Business Wire
How Illumina's Q1 Results Delighted Investors
April 28, 2021
Nearly everything went right for the genomic sequencing pioneer.
Via
The Motley Fool
Illumina Inc (ILMN) Q1 2021 Earnings Call Transcript
April 28, 2021
ILMN earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Illumina: Q1 Earnings Insights
April 27, 2021
Shares of Illumina (NASDAQ:ILMN) rise in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 15.24% year over year to $1.89,...
Via
Benzinga
Illumina Stock Dips Despite First-Quarter Beat, Strong Earnings Guide
April 27, 2021
Illumina stock skidded on Tuesday after the medical technology giant reported adjusted income of $1.89 per share on $1.09 billion in sales.
Via
Investor's Business Daily
Tuesday Market Report
April 27, 2021
Swiss ABB gained 0.8% more today after it reported on its Q1 today, confirming the pre-announced data from earlier in April.
Via
Talk Markets
Illumina Reports Financial Results for First Quarter of Fiscal Year 2021
April 27, 2021
From
Illumina, Inc.
Via
Business Wire
Microfluidics Market Next Big Thing : Biggest Opportunity of 2021 - Qiagen, Abbott Laboratories, Fluidigm Corporation
April 27, 2021
Edison, NJ -- (SBWIRE) -- 04/27/2021 -- The microfluidics market is segmented into in-vitro diagnostics, pharmaceutical, life science research & manufacturing, and therapeutics. The in-vitro...
Via
SBWire
Exposures
COVID-19
Illumina Is One of the 2021 TIMES Most Influential Companies
April 27, 2021
SOURCE: Illumina
Via
3BL Media
Exposures
COVID-19
Asia Pacific Single-Cell Analysis Market Worth $1,375 Million by 2025 – Impact of Covid 19 Detailed Analysis
April 27, 2021
The asia pacific single-cell analysis market is projected to reach $1,375 million by 2025. APAC single-cell analysis market report provides crucial industry insights that will help your business grow.
Via
SBWire
Exposures
COVID-19
The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout
April 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Illumina Named One of Singapore's Best Employers
April 27, 2021
SOURCE: Illumina
Via
3BL Media
Molecular Diagnostics Market Worth $31.8 Billion by 2026 - Exclusive Report by MarketsandMarkets™
April 26, 2021
The global molecular diagnostics market size is projected to reach $31.8 billion by 2026. Oncology testing market report provides crucial industry insights that will help your business grow.
Via
SBWire
Exposures
COVID-19
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
April 24, 2021
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...
Via
Benzinga
Exposures
Product Safety
3 Healthcare Stocks About to be Bolstered by Biden's American Rescue Plan
April 24, 2021
The government is going to invest heavily in COVID-19 research and tracking, and these companies are likely to benefit.
Via
The Motley Fool
Exposures
COVID-19
Illumina, Kartos Therapeutics Team Up To Develop Companion Diagnostic For TP53-Haboring Cancer Indications
April 23, 2021
Illumina Inc (NASDAQ: ILMN) and privately-held Kartos Therapeutics have announced a partnership to develop a next-generation sequencing-based TP53 companion...
Via
Benzinga
The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs
April 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:...
Via
Benzinga
Tesla Hit As The QQQ, SPY And DIA All Fell Today. Here's Why.
April 22, 2021
U.S. indices traded lower Thursday on reports President Biden will propose a capital gains tax for the wealthy of up to 43.4%, which...
Via
Benzinga
Illumina and Kartos Therapeutics Announce New Oncology Partnership to Develop an NGS-Based TP53 Companion Diagnostic
April 22, 2021
From
Illumina, Inc.
Via
Business Wire
Plant Genomics Market Growth Analysis Report, Insights, Outlook, Industry Analysis, Share, Trends, Applications, Types and Forecasts 2028
April 22, 2021
This report provides detailed historical analysis of global market for Plant Genomics from 2014-2019, and provides extensive market forecasts from 2020-2028 by region/country and subsectors.
Via
SBWire
Exposures
COVID-19
Tumor Genomics Industry Trends, Revenue, Size, Analysis, Key Players, Growth, Share and Forecast Till 2028
April 22, 2021
Increasing number of cancer cases, rising government initiatives and projects, new drug developments, and increasing demand for cancer-specific diagnostics are factors driving global tumor genomic...
Via
SBWire
Exposures
COVID-19
< Previous
1
2
...
25
26
27
28
29
30
31
32
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.